Special Report By Andrew Joseph The surgeon general and his brother: A family’s painful reckoning with addiction
Special Report By David Armstrong 52 weeks, 52 faces: Obituaries narrate lives lost to the opioid epidemic
First Opinion By Seth Mnookin I told my doctors my drug history. Yet they gave me opioids without counseling
First Opinion By Daniel Wolfe Vivitrol offers the fantasy of being drug-free. But that’s not the most important thing in tackling addiction
Special Report By David Armstrong Dope Sick: A harrowing story of best friends, addiction — and a stealth killer
First Opinion By Jeffrey Samet, Michael Botticelli, and Monica Bharel It’s time for methadone to be prescribed as part of primary care
First Opinion By David A. Patterson Silver Wolf Real-time data are essential for Covid-19. They’re just as important for the opioid overdose crisis
Exclusive By Shraddha Chakradhar and Casey Ross The history of OxyContin, told through unsealed Purdue documents
First Opinion By Sean Fogler As a physician and a patient, I’ve seen the damage caused by the stigma of addiction. It must end
First Opinion By Richard Bottner, Christopher Moriates, and Matthew Stefanko Stigma is killing people with substance use disorders. Health care providers need to rid themselves of it
Health By Alice Proujansky Pregnancy poses challenges for people in recovery from substance use disorder. Covid-19 is taxing their support system
Health Tech By Erin Brodwin Nearly a year since opening its doors, here’s how Verily’s addiction medicine campus is taking shape
Politics By Amy Sokolow Opioid overdoses have skyrocketed amid the coronavirus, but states are nevertheless slashing addiction treatment program budgets
Pharmalot By Ed Silverman A pill to fight alcoholism causes an uproar in France over a regulator’s view of a clinical trial
Pharmalot By Ed Silverman Despite evidence, many primary care doctors don’t want to prescribe medications for addiction
Health By Alison Insinger Methadone clinic lines and packed waiting rooms leave clients vulnerable to the coronavirus
First Opinion By Miriam Komaromy and Michael Botticelli A radical approach to preventing Covid-19 infection in the homeless
First Opinion By Ximena A. Levander and Sarah E. Wakeman Covid-19 will worsen the opioid overdose crisis if we don’t prepare now
First Opinion By Haider J. Warraich What an 1890s opioid epidemic can teach us about ending addiction today
Business By Andrew Joseph Prosecutors identified ‘Pharma Co. X’ as central to alleged opioid kickback scheme. Was it Purdue?
First Opinion By Lila Flavin and J. Wesley Boyd A government database is supposed to help people seeking treatment for opioid addiction. It often doesn’t
Health By Andrew Joseph and Shraddha Chakradhar Faced with prescriber fears of OxyContin misuse, Purdue sales reps misleadingly played up drug’s safety, documents show
Health Tech By Casey Ross Pear Therapeutics licenses voice biomarkers for dementia and psychiatric disorders
Health By Lev Facher This mental health advocate wants to make addiction and behavioral health a 2020 election issue
First Opinion By Lauren Lollini A hospital staffer diverted drugs, which gave me hepatitis C. That happens more often than you think
Health By Andrew Joseph National Academies outlines opioid guidelines, aiming to make approach to prescribing more consistent
Politics By Lev Facher FDA blasts Alkermes for underselling the risks of opioid addiction drug Vivitrol
First Opinion By Patrick J. Kennedy Mental health and addiction care are poorly covered by insurance networks
Health By Andrew Joseph Tufts will scour Sackler name from its medical campus, in rebuff of family that controls Purdue Pharma
Exclusive By Casey Ross Purdue’s Richard Sackler proposed plan to play down OxyContin risks, and wanted drug maker feared ‘like a tiger,’ files show